For nearly two decades, the fight against HIV/AIDS in Southern Africa was defined by a steady, predictable flow of American resources. In the early 2000s, in what was then Swaziland—now Eswatini—the virus was not just a health crisis. it was an existential threat. At the time, more than a quarter of adults were infected, and projections suggested the virus could potentially wipe out the entire nation.
That trajectory was fundamentally altered by the President’s Emergency Plan for AIDS Relief (PEPFAR), the largest commitment by any nation to address a single disease. However, a recent shift in U.S. Global health aid strategy is now introducing a volatile era of uncertainty for the clinicians and nonprofits who have spent twenty years building this infrastructure. As the U.S. Pivots toward an “America First” approach, the transition is leaving critical programs in a state of flux, risking the reversal of hard-won clinical gains.
The core of the tension lies in a systemic overhaul: the U.S. Government is moving away from its long-standing reliance on nonprofits and international organizations to deliver care. Instead, the administration is negotiating new, direct agreements with individual governments. Whereas the stated goal is to increase sovereign ownership of health systems, the implementation has been marred by missed deadlines and delayed payments, leading to what some experts describe as a “planned sunset” of existing lifesaving initiatives.
For those on the front lines, the result of these global health aid cuts and administrative shifts is not a theoretical policy debate, but a tangible loss of services. Dr. Caspian Chouraya, who oversees HIV work for the Elizabeth Glaser Pediatric AIDS Foundation across countries including Uganda, Malawi, Tanzania, Lesotho, Kenya, Mozambique, and Côte d’Ivoire, has seen the immediate impact. Projects that provided critical support groups for teenagers with HIV and cell phone plans that allowed clinics to maintain contact with patients have already been shut down.
The Failure of ‘Bridge Funding’
To manage the transition to government-to-government contracts, the U.S. Implemented a system of “bridge funding”—short-term grants intended to keep programs running while new implementation plans were hammered out. The administration set a six-month deadline to finalize these new contracts, but the timeline proved unrealistic for the complexity of the task.
The instability was compounded when the second installment of these bridge funds, scheduled for December, failed to arrive on time. In some regions, the money did not materialize until March, months after it was due. This lag created a precarious environment where health facilities were forced to begin winding down operations just as the funds finally arrived.
“Am I in? Am I out? Am I in? Am I out? What’s happening?”
Dr. Chouraya describes this cycle of uncertainty as a primary driver of instability. The impact extends beyond patient care to the workforce itself. In many of the countries where the U.S. Operates, labor laws require several months’ notice before staff can be laid off. Without guaranteed funding, organizations face the risk of costly litigation and labor law violations if they cannot provide those notices or pay final contracts.
The Disconnect Between Appropriation and Disbursement
One of the most confounding aspects of the current crisis is that the funding exists. Congress has continued to push back against proposed cuts, appropriating $6 billion this fiscal year to fight HIV/AIDS worldwide—the same amount provided in the previous year. However, there is a growing gap between the money appropriated by Congress and the money actually disbursed to the field.
K.J. Seung, of the Division of Global Health Equity at Brigham and Women’s Hospital, notes that while the total amount of money remains unchanged, the delivery mechanism has stalled. This suggests that the instability is not a result of a lack of funds, but a deliberate choice in how—or if—those funds are deployed.
| Feature | Traditional Model | “America First” Strategy |
|---|---|---|
| Primary Partners | Nonprofits & Intl. Organizations | Direct Government Agreements |
| Funding Flow | Consistent, Grant-Based | Bridge Funding $\rightarrow$ G2G Contracts |
| Implementation | NGO-led clinical delivery | State-led health systems |
| Risk Factor | Dependency on foreign NGOs | Administrative delays/Political instability |
A Strategic Pivot or a Systematic Decline?
The State Department has defended the shift, calling claims of a program shutdown a “mischaracterization.” In official statements, the department maintains that every dollar appropriated for global HIV is being spent and that funds are simply being directed more strategically to ensure long-term sustainability through government ownership.
However, critics argue that the transition is being handled with a level of inefficiency that borders on waste. Emily Bass, author of To Finish A Plague: America’s Fight To Defeat AIDS In Africa, suggests that the fragmented timeline of six-month and three-month extensions provides a lower return on investment than a stable, long-term program. According to Bass, the current approach is “no way to run a health initiative.”
From a clinical perspective, the danger of this instability cannot be overstated. HIV treatment requires strict adherence to antiretroviral therapy (ART). When clinics lose the ability to track patients via cell phones or when support systems for adolescents vanish, the risk of treatment interruption increases. Such interruptions can lead to drug resistance, making the virus harder to treat and increasing the likelihood of transmission within the community.
The psychological toll on the health workforce is as well mounting. Dr. Chouraya notes that staff are reaching a breaking point, with many feeling that there is no longer a viable future in the field of global HIV response due to the unpredictability of U.S. Support.
Disclaimer: This article is provided for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The next critical checkpoint for these programs will be the evaluation of the renewed government-to-government agreements currently under negotiation. Whether these contracts can be finalized and funded before the remaining bridge extensions expire will determine if the U.S. Maintains its role as the primary bulwark against the epidemic in Sub-Saharan Africa.
We invite readers to share their perspectives on the evolution of global health diplomacy in the comments below.
